User menu

Impact of pathogen inactivation (INTERCEPT Blood System (TM)) on platelet utilization during three years of routine use

Bibliographic reference Osselaer, Jean-Claude ; Doyen, Chantal ; Chatelain, Christian ; DEBRY, Cécile ; Goffaux, M. ; et. al. Impact of pathogen inactivation (INTERCEPT Blood System (TM)) on platelet utilization during three years of routine use.60th Annual Meeting of the American-Association-of-Blood-Banks (Anaheim(Ca), Oct 20-23, 2007). In: Transfusion, Vol. 47, no. 3, p. 18A-19A (2007)
Permanent URL http://hdl.handle.net/2078.1/59558
  1. He CW, Ai Zheng, 24, 646 (2005)
  2. Leung Ray K.M., Whittaker Paul A., RNA interference: From gene silencing to gene-specific therapeutics, 10.1016/j.pharmthera.2005.03.004
  3. Miller V. M., Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles, 10.1093/nar/gkh208
  4. Pardridge William M, Intravenous, non-viral RNAi gene therapy of brain cancer, 10.1517/14712598.4.7.1103
  5. Ishizuya-Oka Atsuko, Epithelial-Connective Tissue Cross-Talk Is Essential for Regeneration of Intestinal Epithelium, 10.1272/jnms.72.13
  6. Perrier A. L., Tabar V., Barberi T., Rubio M. E., Bruses J., Topf N., Harrison N. L., Studer L., Derivation of midbrain dopamine neurons from human embryonic stem cells, 10.1073/pnas.0404700101
  7. Tran Simon D, Pillemer Stanley R, Dutra Amalia, Barrett A John, Brownstein Michael J, Key Sharon, Pak Evgenia, Leakan Rose Anne, Kingman Albert, Yamada Kenneth M, Baum Bruce J, Mezey Eva, Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study, 10.1016/s0140-6736(03)12894-2
  8. Ahsan T, Nerem RM, Bioengineered tissues: the science, the technology, and the industry, 10.1111/j.1601-6343.2005.00326.x
  9. Shufaro Yoel, Reubinoff Benjamin E., Therapeutic applications of embryonic stem cells, 10.1016/j.bpobgyn.2004.07.002
  10. Krensky AM, Kidney Int Suppl, 58, S2 (1997)
  11. Hernandez-Fuentes MP, Rev Immunogenet, 1, 282 (1999)
  12. Hansen John A., T-cell alloreactivity in hematopoietic stem cell transplantation, 10.1016/j.bbmt.2004.11.013
  13. Strom T.B., Field L.J., Ruediger M., Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine, 10.1016/s0041-1345(01)02303-x
  14. Down Julian D., White-Scharf Mary E., Reprogramming Immune Responses: Enabling Cellular Therapies and Regenerative Medicine, 10.1634/stemcells.21-1-21
  15. Elbashir S. M., RNA interference is mediated by 21- and 22-nucleotide RNAs, 10.1101/gad.862301
  16. Saito Yoriko, Dzik Sunny, Gene knockdown: RNA-interference is coming of age, 10.1111/j.1537-2995.2005.04282.x
  17. An Dong Sung, Xie Yiming, Mao Si Hua, Morizono Kouki, Kung Sam K.P., Chen Irvin S.Y., Efficient Lentiviral Vectors for Short Hairpin RNA Delivery into Human Cells, 10.1089/104303403322168037
  18. Li M, Methods Mol Biol, 309, 261 (2005)
  19. Paddison P. J., Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells, 10.1101/gad.981002
  20. Beyer Florian, Doebis Cornelia, Busch Annette, Ritter Thomas, Mhashilkar Abner, Marasco Wayne M., Laube Horst, Volk Hans-Dieter, Seifert Martina, Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells—new perspectives for the generation of universal donor cells for tissue transplantation, 10.1002/jgm.548
  21. BUSCH A, MHC class I manipulation on cell surfaces by gene transfer of anti-MHC class I intrabodies?a tool for decreased immunogenicity of allogeneic tissue and cell transplants, 10.1016/j.ymeth.2004.03.017
  22. Mhashilkar AM, Doebis C, Seifert M, Busch A, Zani C, Soo Hoo J, Nagy M, Ritter T, Volk H-D, Marasco WA, Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes, 10.1038/sj.gt.3301656
  23. Abstract session II – New developments, 10.1038/sj.gene.6364076
  24. Figueiredo Constança, Seltsam Axel, Blasczyk Rainer, Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery, 10.1007/s00109-005-0024-2
  25. Gonzalez Sergio, Castanotto Daniela, Li Haitang, Olivares Simon, Jensen Michael C., Forman Stephen J., Rossi John J., Cooper Laurence J.N., Amplification of RNAi—Targeting HLA mRNAs, 10.1016/j.ymthe.2004.12.023
  26. Wiznerowicz M., Trono D., Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference, 10.1128/jvi.77.16.8957-8951.2003
  27. Terasaki Paul I., Bernoco Domenico, Park Min Sik, Ozturk Gungor, Iwaki Yuichi, Microdroplet Testing for HLA-A, -B, -C, and -D Antigens: The Philip Levine Award Lecture, 10.1093/ajcp/69.2.103
  28. Jedema I., New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population, 10.1182/blood-2003-06-2070
  29. Beckman Evan M., Porcelli Steven A., Morita Craig T., Behar Samuel M., Furlong Stephen T., Brenner Michael B., Recognition of a lipid antigen by CD1-restricted αβ+ T cells, 10.1038/372691a0
  30. Abbas-Terki Toufik, Blanco-Bose William, Déglon Nicole, Pralong William, Aebischer Patrick, Lentiviral-Mediated RNA Interference, 10.1089/104303402320987888
  31. Boden Daniel, Pusch Oliver, Lee Fred, Tucker Lynne, Ramratnam Bharat, Efficient Gene Transfer of HIV-1-Specific Short Hairpin RNA into Human Lymphocytic Cells Using Recombinant Adeno-associated Virus Vectors, 10.1016/j.ymthe.2003.11.025
  32. Scherr Michaela, Battmer Karin, Ganser Arnold, Eder Matthias, Modulation of Gene Expression by Lentiviral-Mediated Delivery of Small Interfering RNA, 10.4161/cc.2.3.376
  33. Clark Rachael, Kupper Thomas, Old Meets New: The Interaction Between Innate and Adaptive Immunity, 10.1111/j.0022-202x.2005.23856.x
  34. Bradley J. A., Bolton E. M., Pettigrew G., Monitoring T cell alloreactivity after organ transplantation, 10.1111/j.1365-2249.2005.02943.x
  35. Moll Solange, Pascual Manuel, Humoral Rejection of Organ Allografts, 10.1111/j.1600-6143.2005.01086.x
  36. Olszewski WL, Ann Transplant, 10, 5 (2005)
  37. Varnavidou-Nicolaidou Agathi, Iniotaki-Theodoraki Aliki G., Doxiadis Ilias I.N., Georgiou Dora, Patargias Theocharis, Stavropoulos-Giokas Catherine, Kyriakides George, Expansion of Humoral Donor-Specific Alloreactivity After Renal Transplantation Correlates With Impaired Graft Outcome, 10.1016/j.humimm.2005.07.002
  38. Waller Edmund K, Cellular immunotherapy and cancer, 10.1053/j.seminoncol.2004.02.021
  39. Demanet C., Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?, 10.1182/blood-2003-07-2500
  40. Carbone E., HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells, 10.1182/blood-2004-04-1422